Shanghai Hutchison Pharmaceuticals Limited
Clinical trials sponsored by Shanghai Hutchison Pharmaceuticals Limited, explained in plain language.
Develops and commercializes oncology and immunology drugs.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Herbal pill shows promise for neck nerve pain in new trial
Disease control CompletedThis study tested whether a Chinese herbal pill called Shenqi Sherong Pill can help people with mild to moderate cervical spondylotic myelopathy, a condition where the spinal cord in the neck is compressed. 428 adults aged 18-75 took either the herbal pill or a placebo three time…
Phase: PHASE3 • Sponsor: Shanghai Hutchison Pharmaceuticals Limited • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New stroke drug shows promise in early trial
Disease control CompletedThis study tested a new drug called SHPL-49 in 270 people who had an acute ischemic stroke. Participants received either the drug or a placebo as an IV infusion twice daily for 7 days. The goal was to see if the drug helps improve recovery and is safe to use.
Phase: PHASE2 • Sponsor: Shanghai Hutchison Pharmaceuticals Limited • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC